Phase 2 Pertussis Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Tetanus-diphtheria-acellular Pertussis (Tdap)
GC Biopharma Corp120 enrolled1 locationNCT06997627
Recruiting
Phase 2Phase 3
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Terminated
Phase 2
A Clinical Trial to Assess the safety and immunogenicity of a combined Tetanus, Diphtheria, Acellular Pertussis and Poliomyelitis Vaccine (SIIPL Tdap-IPV) compared with Boostrix-IPV in Healthy Adults, Adolescents and Children
DiphtheriaPolioPertussis+1 more
Serum Institute of India Pvt Ltd204 enrolled1 locationACTRN12620000848909
Completed
Phase 2Phase 3
Pertaprime: A study to assess the immune response and safety of a new pertussis vaccine (Pertagen®) in healthy young adults.
Pertussis prevention
Telethon Kids Institute102 enrolled1 locationACTRN12619000944134
Not Yet Recruiting
Phase 2
Immunogenicity and safety of acellular pertussis (whooping cough) vaccine at birth
whooping cough (pertussis)
Peter McIntyre400 enrolled1 locationACTRN12609000905268